Drug Shortage Report for TRIFLUOPERAZINE
| Report ID | 75655 |
| Drug Identification Number | 00345539 |
| Brand name | TRIFLUOPERAZINE |
| Common or Proper name | Trifluoperazine |
| Company Name | AA PHARMA INC |
| Market Status | DORMANT |
| Active Ingredient(s) | TRIFLUOPERAZINE |
| Strength(s) | 1MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 100BTL |
| ATC code | N05AB |
| ATC description | ANTIPSYCHOTICS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2019-03-15 |
| Estimated end date | 2022-10-15 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2022-01-26 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1165 CREDITSTONE ROAD VAUGHAN, ONTARIO CANADA L4K 4N7 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v1 | 2019-02-13 | English | Compare |
| v2 | 2019-02-13 | French | Compare |
| v3 | 2019-02-16 | English | Compare |
| v4 | 2019-03-06 | English | Compare |
| v5 | 2019-03-06 | French | Compare |
| v6 | 2019-03-21 | English | Compare |
| v7 | 2019-03-21 | French | Compare |
| v8 | 2019-04-29 | English | Compare |
| v9 | 2019-04-29 | French | Compare |
| v10 | 2019-06-05 | English | Compare |
| v11 | 2019-06-05 | French | Compare |
| v12 | 2019-07-31 | English | Compare |
| v13 | 2019-07-31 | French | Compare |
| v14 | 2019-08-22 | English | Compare |
| v15 | 2019-08-22 | French | Compare |
| v16 | 2019-09-13 | English | Compare |
| v17 | 2019-09-13 | French | Compare |
| v18 | 2020-01-13 | English | Compare |
| v19 | 2020-01-13 | French | Compare |
| v20 | 2021-06-17 | English | Compare |